ARTICLE | Clinical News
Narusus regulatory update
April 4, 2017 9:49 PM UTC
Japan approved Narusus hydromorphone tablets from Daiichi to treat cancer pain. The product is a once-daily, extended-release formulation of hydromorphone. Daiichi also said Japan approved Narurapid h...
BCIQ Company Profiles
BCIQ Target Profiles